INFORM2 Exploratory Multinational Phase I/II Combination Study of Nivolumab and Entinostat in Children and Adolescents With Refractory High-risk Malignancies
ACTRN 12619001768189 Brief Summary The aim of this clinical trial is to…
Read more arrow_forward